
    
      Patients with chronic heart failure of ischemic origin (120) Stable coronary artery disease
      Acute coronary syndromes > 3 months Revascularization procedures > 3 months Naive on heart
      rate reducing agents New York Heart Association (NYHA) Class II III 6 minute walking test
      (6MW) tolerance between 200 and 400 m Stable medications for the past 3 months

      Treatment Ivabradine up to 7.5 mg b.i.d. Carvedilol up to 25 mg b.i.d. Carvedilol and
      Ivabradine up to 12.5/5 mg b.i.d.

      Efficacy measure Intention to treat Exercise tolerance Quality of life
    
  